FDA announces record generic approvals in 2019

21-10-2019

Rory O'Neill

FDA announces record generic approvals in 2019

Jarretera / Shutterstock.com

The US Food and Drug Administration (FDA) has announced record approvals of generic drugs in 2019, amid growing pressure over drug prices in the US.


US Food and Drug Administration, Ned Sharpless, generics, drug prices, FDA, Naxolone, Narcan, Teva, Pfizer, anti-competition, AB824, pay-for-delay

More on this story

California outlaws pay-for-delay deals
09-10-2019

LSIPR